Periodic safety reporting schedule
Active Substances | Trade Name | MAH | Year of registration in Saudi Arabia | International Birth Date (IBD) | PSUR Submission Frequency | Data Lock Point (DLP) | Submission Date |
---|---|---|---|---|---|---|---|
Ceftazidime | FORTA-Z | Jazeera Pharmaceutical Industries (JPI) | 3 years | ||||
Ceftazidime | FORTUM | GLAXOSMITHKLINE (GSK) | 3 years | ||||
CLINDAMYCIN PHOSPHATE | MEDACIN -T 1% TOPICAL SOLUTION | MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES | 3 years | ||||
CLINDAMYCIN PHOSPHATE | MEDACIN -T 1% GEL | MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES | 3 years | ||||
Clindamycin Hydrochloride | DALACIN | PFIZER | 3 Years | ||||
OBINUTUZUMAB | Gazyva | ROCHE | 6 months | ||||
Methylphenidate | Ritalin | NOVARTIS | annual | ||||
SEVELAMER HYDROCHLORIDE | Renagel | SANOFI PASTEUR | annual | ||||
SEVELAMER CARBONATE | Renvela | SANOFI PASTEUR | annual | ||||
Human coagulation factor VIII/human von Willebrand factor | Koate | INSTITUTO GRIFOLS | 3 years |